Matches in Nanopublications for { ?s ?p "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- NP774666.RAmLoJxKwkkWpw_YqLtbbEz2yoJ9no0-cbRytFM8Q2ak8130_assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP774666.RAmLoJxKwkkWpw_YqLtbbEz2yoJ9no0-cbRytFM8Q2ak8130_provenance.
- NP926359.RAnsX10YlO2hiW0tCNW9nv4OgyR-WAFbWwNBYXhE3O4Uk130_assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926359.RAnsX10YlO2hiW0tCNW9nv4OgyR-WAFbWwNBYXhE3O4Uk130_provenance.
- NP433499.RAR9BoOG6sJosHpVW_2pA15pN_gFwJwld-8IruVaJ_JWg130_assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433499.RAR9BoOG6sJosHpVW_2pA15pN_gFwJwld-8IruVaJ_JWg130_provenance.
- NP315556.RAGDSGpeHMJOQRQKB6mv9NKuXSPXBtpVGJ_CUe7Qdr7CQ130_assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315556.RAGDSGpeHMJOQRQKB6mv9NKuXSPXBtpVGJ_CUe7Qdr7CQ130_provenance.
- NP500523.RAdwXys3jCarKjSEvqybpSNKIWaOFe4jkAdTTOYimP_qk130_assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500523.RAdwXys3jCarKjSEvqybpSNKIWaOFe4jkAdTTOYimP_qk130_provenance.
- assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP961991.RARcb3yC0HDDvI1AiteprgraplSNinVIGfUIS4LwDaPgU130_assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961991.RARcb3yC0HDDvI1AiteprgraplSNinVIGfUIS4LwDaPgU130_provenance.
- assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1006451.RAvoourFn-4hZPNi6GzaRqvUZcMtYaCz58dvytL5g8gfk130_assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006451.RAvoourFn-4hZPNi6GzaRqvUZcMtYaCz58dvytL5g8gfk130_provenance.
- NP500612.RA8KnYPf3Xi_MsQN6QTiwqNKyyP8b1O3Xj1OdnB3EgwrU130_assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500612.RA8KnYPf3Xi_MsQN6QTiwqNKyyP8b1O3Xj1OdnB3EgwrU130_provenance.
- NP1006447.RA23AfKyUaNDShPCV5_0ljn9k8CCK8kvd6eXuKWTiZQ9E130_assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006447.RA23AfKyUaNDShPCV5_0ljn9k8CCK8kvd6eXuKWTiZQ9E130_provenance.
- NP1006450.RAw4Vg0dUynvRi-m55dluQTZWHD1j0-fV7V-eL8zC1B9Q130_assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006450.RAw4Vg0dUynvRi-m55dluQTZWHD1j0-fV7V-eL8zC1B9Q130_provenance.
- NP1006452.RA2C9PjXTtwHlMl2XzyQNKeztK19MOLeWfRSI8qIacIP0130_assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006452.RA2C9PjXTtwHlMl2XzyQNKeztK19MOLeWfRSI8qIacIP0130_provenance.
- NP961966.RAzrZnC6pnCToQuZm7cv13UAw1g5n_3pb1OtWb-4HIEoY130_assertion description "[BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP961966.RAzrZnC6pnCToQuZm7cv13UAw1g5n_3pb1OtWb-4HIEoY130_provenance.